Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CF101 in Active Rheumatoid Arthritis with Elevated A3AR
NCT01034306Phase 2Completed
- Sponsor
- Can-Fite BioPharma Ltd.
- Start
- Oct 2010
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of piclidenoson in rheumatoid arthritis (RA), sponsored by Can-Fite BioPharma Ltd.. Started Oct 2010; status: completed.
02
Drugs
piclidenoson
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01034306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01034306.